MicroRNA-124 expression in Kupffer cells modulates liver injury by targeting IL-6/STAT3 signaling

Jinyu Wang1, Xueyun Zhang1, Jiajia Han1

  • 1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.

Antiviral Research
|December 29, 2022
PubMed

Insights

Serum microRNA-124 (miR-124) predicts prognosis in hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). MiR-124 reduces liver inflammation by inhibiting IL-6/STAT3 signaling, offering a potential therapeutic target for liver injury.

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • Chronic hepatitis B (CHB) and hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) are significant causes of liver injury.
  • The precise mechanisms by which microRNA-124 (miR-124) influences liver inflammation in these conditions are not fully understood.

Purpose of the Study:

  • To investigate the role of miR-124 in liver inflammation and its potential as a predictive biomarker in HBV-ACLF.
  • To elucidate the molecular mechanism through which miR-124 regulates liver injury.

Main Methods:

  • Analysis of serum miR-124 levels in patients with HBV-ACLF.
  • Utilizing a mouse model of concanavalin A-induced acute liver injury.
  • Investigating the effect of miR-124 overexpression on interleukin-6 (IL-6) secretion and liver necrosis.
  • Identifying the direct target of miR-124 using molecular assays.

Main Results:

  • Serum miR-124 levels were found to be a compensatory predictive factor for organ failure and 28-day prognosis in HBV-ACLF patients.
  • In a mouse model, miR-124 was highly expressed in Kupffer cells and its overexpression reduced IL-6 secretion and liver necrosis.
  • MiR-124 was shown to directly target the 3'-untranslated region of signal transducer and activator of transcription 3 (STAT3), inhibiting the IL-6/STAT3 signaling pathway.
  • This inhibition led to reduced pro-inflammatory Kupffer cell polarization.

Conclusions:

  • MiR-124 shows potential as a predictive biomarker for HBV-ACLF prognosis.
  • MiR-124 may serve as a therapeutic target for mitigating severe liver injury associated with cytokine storms in HBV-ACLF.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K